Home » Topics » Disease categories and therapies » Infection

Infection
RSS

News from ICAAC: new carbapenem with high activity against MRSA and PRSP

Sep. 21, 2000

Meningococcal sepsis trial reveals benefits for rBPI21 treatment

Sep. 21, 2000

New broad-spectrum antibacterial agents derived from erythromycin

Sep. 20, 2000

Candidate for Rx of Gram-positive infections selected at Daiichi

Sep. 20, 2000

ICAAC news: first report of potential anti-flu agent with novel mode of action

Sep. 20, 2000

BMS-247243, a new anti-MRSA cephem, debuts at ICAAC

Sep. 20, 2000

Sankyo presents preclinical profile of promising new triazole antifungal agent

Sep. 20, 2000

Preclinical activity, pharmacokinetics and toxicity reported for novel parenteral carbapenem

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

Takeda presents newest antifungal candidates this week in Toronto

Sep. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...